Clinical Trial

Titration of Inspired Oxygen to Decrease the Incidence of Postoperative Pulmonary Complications

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 31, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
Lung cancer is with the highest incidence rate and mortality among people over 60 years old in China. Postoperative pulmonary complications (PPCs) is the most common complication after pneumonectomy, which has a significant impact on the short-term and long-term prognosis of patients, and is even the primary risk factor leading to early postoperative death. High fraction of inspired oxygen (FiO2) is an independent risk factor for PPCs, but it is difficult to achieve oxygenation while avoiding hyperxemia during one lung ventilation (OLV). We will randomly divide patients who plan to undergo thoracoscopic pulmonary resection into two groups. During OLV, titration will be used to determine the optimal FiO2 for titration group while FiO2 of 80% will be used for mechanical ventilation for control group. The incidence of postoperative PPCs, hypoxia/hyperxemia, severity level of postoperative PPC, postoperative 30 day PPC, increased hospitalization costs, and prolonged hospital stay will be observed in both groups of patients.We will evaluate the effectiveness and safety of titrating inhaled oxygen concentration in lung protection during OLV.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-01-28; most recent amendment 2024-10-29.
Status change: Not Yet Recruiting → Recruiting 2024-06-19
Trial Details
NCT Number NCT06243146
Lead Sponsor Sichuan Provincial People's Hospital
Conditions Unrecognized Condition
Enrollment 156 participants
Start Date 2024-06-20
Primary Completion 2024-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-10-31